Redwood Grove Capital LLC Acquires Shares of 59,070 Humana Inc. $HUM

Redwood Grove Capital LLC acquired a new stake in Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 59,070 shares of the insurance provider’s stock, valued at approximately $23,464,000. Humana comprises about 5.9% of Redwood Grove Capital LLC’s portfolio, making the stock its 4th largest position.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in HUM. Montag A & Associates Inc. raised its holdings in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in Humana in the second quarter valued at $26,000. Fideuram Asset Management Ireland dac purchased a new stake in Humana in the fourth quarter valued at $27,000. Trust Co. of Vermont acquired a new stake in Humana during the 2nd quarter worth about $28,000. Finally, Reflection Asset Management acquired a new stake in Humana during the 4th quarter worth about $29,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

HUM has been the subject of several analyst reports. Bank of America raised Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective for the company in a report on Wednesday, July 29th. Zacks Research lowered Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Barclays lifted their price target on Humana from $344.00 to $407.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Royal Bank Of Canada upped their price objective on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $403.91.

Humana Trading Up 0.6%

HUM stock opened at $388.92 on Wednesday. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market cap of $46.70 billion, a P/E ratio of 36.79, a PEG ratio of 2.20 and a beta of 0.72. The company’s 50-day simple moving average is $383.88 and its 200-day simple moving average is $285.00.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.Humana’s revenue for the quarter was up 26.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.27 EPS. As a group, equities analysts forecast that Humana Inc. will post 9.12 EPS for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.